Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 6, 2016

Primary Completion Date

June 21, 2016

Study Completion Date

June 29, 2017

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

BI 695501 Autoinjector

DRUG

BI 695501 Prefilled syringe

Trial Locations (19)

21502

Klein and Associates, M.D., P.A., Cumberland

34292

Lovelace Scientific Resources, Incorporated, Venice

75231

Metroplex Clinical Research Center, Dallas

77058

Heartland Research Associates, LLC, Nassau Bay

77065

Rheumatology Clinic Of Houston, P.A., Houston

79424

Arthritis & Osteoporosis Associates LLP, Lubbock

87102

Albuquerque Center For Rheumatology, Albuquerque

91786

Inland Rheumatology Clinical Trials, Inc., Upland

01605

Clinical Pharmacology Study Group, Worcester

15-099

Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk, Bialystok

85-168

Szpital Uniwersytecki nr 2 im.dr J. Biziela, Bydgoszcz

82-300

Wojewodzki Szpital Zespolony w Elblagu, Elblag

81-338

Medica Pro Familia Spolka Akcyjna, Oddzial w Gdyni, Gdynia

40-954

Medical Centre Pratia Katowice I, Katowice

30-002

Medical Centre Pratia Krakow, Krakow

31-023

Specialist Center ALL-MED, Krakow, Krakow

87-100

"Niepubliczny ZOZ, Nasz Lekarz, Lekarzy Rodzinnych z", Torun

01-868

Medical Centre Pratia Warszawa, Warsaw

51-128

Wojewodzki Szpital Specjalistyczny we Wroclawiu, Wroclaw

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY